Status:
UNKNOWN
Improving Information to Caregivers Via Adaptation and Implementation of the HERMES Intervention
Lead Sponsor:
Bispebjerg Hospital
Collaborating Sponsors:
Herlev Gentofte University Hospital, Denmark
Rigshospitalet, University of Copenhagen, Denmark
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The HERMES intervention was developed in a Danish setting after a comprehensive investigation on caregivers' needs. The intervention consists of: 1) a systematic identification of the caregiver's unme...
Eligibility Criteria
Inclusion
- Adult (18+ years)
- Primary caregiver (defined as the lay person (partner, family member, friend, etc) most involved in the patient's disease course. The primary caregiver is appointed by the patient)
- Caregiver of an adult cancer patient starting up a treatment course in an oncological department
- Written informed consent to participation
Exclusion
- Caregivers not able to read and understand Danish
- Caregivers with no or minimal contact to the oncological department
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 15 2022
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04437563
Start Date
February 1 2021
End Date
July 15 2022
Last Update
March 2 2022
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg Universitetshospital
Aalborg, Denmark
2
Rigshospitalet
Copenhagen, Denmark, 2100
3
Herlev Hospital
Herlev, Denmark
4
Hospitalsenheden Vest
Herning, Denmark